Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |